Your browser doesn't support javascript.
loading
A case report of individualized treatment of high risk and volume metastatic prostate cancer / 中华泌尿外科杂志
Chinese Journal of Urology ; (12): 19-23, 2021.
Article in Zh | WPRIM | ID: wpr-911167
Responsible library: WPRO
ABSTRACT
A 69-year old man presented with high-risk metastatic prostate cancer. After 7 months of androgen deprivation therapy (ADT), he progressed to metastatic castration resistant prostate cancer. We suggested him comprehensive therapy, including Abiraterone, chemo-therapy, radio-therapy, platinum chemo-therapy and Enzalutamide, which proved effective with his long term survival.
Key words
Full text: 1 Index: WPRIM Type of study: Etiology_studies Language: Zh Journal: Chinese Journal of Urology Year: 2021 Type: Article
Full text: 1 Index: WPRIM Type of study: Etiology_studies Language: Zh Journal: Chinese Journal of Urology Year: 2021 Type: Article